NCT00203203View on ClinicalTrials.gov

Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF)

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

August 31, 2008

Study Completion Date

November 30, 2009

Conditions
Ischemic Cardiomyopathy
Interventions
DEVICE

Intramyocardial Injection of stem cells via NOGA Mapping

Subject is randomized to receive intramyocardial injection of stem cells (stem cell therapy) via NOGA mapping to deliver cells in the active arm of the protocol.

OTHER

Control, then Stem Cell Therapy

Subject is randomized to receive a NOGA mapping and no injections (sham treatment)at time of active enrollment and treatment then offered stem cell therapy at 6 months.

Trial Locations (1)

77030

Texas Heart Institute/Baylor St. Luke's Medical Center, Houston

All Listed Sponsors
collaborator

CHI St. Luke's Health, Texas

OTHER

lead

Texas Heart Institute

OTHER

NCT00203203 - Autologous Stem Cells for Cardiac Angiogenesis (FOCUS HF) | Biotech Hunter | Biotech Hunter